SCHEMBL28526623

SCHEMBL28526623

CC=CC(=O)Nc1ccc(Cl)c(Cl)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.59
▸ TP53 P04637 3/20 0.59
▸ EPHX1 P07099 2/20 0.59
▸ EPHX2 P34913 2/20 0.59
▸ CYP3A4 P08684 1/20 0.56
▸ APEX1 P27695 1/20 0.56
▸ CA2 P00918 1/20 0.54
▸ CA4 P22748 1/20 0.54
▸ CA5A P35218 1/20 0.54
▸ CA9 Q16790 1/20 0.54
▸ ALDH1A1 P00352 3/20 0.54
▸ LMNA P02545 2/20 0.54
▸ NPC1 O15118 3/20 0.53
▸ MEN1 O00255 2/20 0.53
▸ KMT2A Q03164 2/20 0.53
▸ KDM4E B2RXH2 2/20 0.53
▸ HTT P42858 2/20 0.53
▸ RAB9A P51151 2/20 0.53
▸ PKM P14618 1/20 0.53
▸ ADORA3 P0DMS8 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15708821 0.89 EPHX1 (0.68) MAPTTP53EPHX1EPHX2CYP3A4
SCHEMBL15709316 0.89 EPHX1 (0.68) MAPTTP53EPHX1EPHX2CYP3A4
SCHEMBL9686565 0.86 EPHX1 (0.63) MAPTTP53EPHX1EPHX2CYP3A4
SCHEMBL11867688 0.83 MAPT (0.51) MAPTTP53CYP3A4ALDH1A1LMNA
SCHEMBL11867696 0.83 MAPT (0.51) MAPTTP53CYP3A4ALDH1A1LMNA
SCHEMBL4786318 0.83 KDM4E (0.74) MAPTTP53EPHX1EPHX2CA2
SCHEMBL4786327 0.83 KDM4E (0.74) MAPTTP53EPHX1EPHX2CA2
SCHEMBL15899245 0.82 IDO1 (0.52) MAPTTP53ALDH1A1LMNAHTT
SCHEMBL15899241 0.82 IDO1 (0.52) MAPTTP53ALDH1A1LMNAHTT
SCHEMBL31704912 0.81 MAPT (0.68) MAPTTP53EPHX1EPHX2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112472699-A Combination methods for improving the therapeutic benefit of bisantrene and derivatives 种族肿瘤学公司 2021-03-12 — — CN disclosed
Send feedback